Header Logo

Connection

JESSICA P HWANG to Neoplasms

Back to Details
This is a "connection" page, showing publications JESSICA P HWANG has written about Neoplasms.
JESSICA P HWANG
Connection Strength
1.843
Neoplasms
  1. Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients. J Natl Cancer Inst. 2023 06 08; 115(6):703-711.
    View in: PubMed
    Score: 0.146
  2. Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204. Support Care Cancer. 2022 Dec 31; 31(1):93.
    View in: PubMed
    Score: 0.142
  3. Practical Implementation of Universal Hepatitis B Virus Screening for Patients With Cancer. JCO Oncol Pract. 2022 09; 18(9):636-644.
    View in: PubMed
    Score: 0.136
  4. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol. 2020 11 01; 38(31):3698-3715.
    View in: PubMed
    Score: 0.120
  5. Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clin Cancer Inform. 2019 03; 3:1-12.
    View in: PubMed
    Score: 0.109
  6. Hepatitis B virus and hepatitis C virus infection in immunocompromised patients. Curr Opin Infect Dis. 2018 12; 31(6):535-541.
    View in: PubMed
    Score: 0.107
  7. Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review. Lancet Haematol. 2018 Oct; 5(10):e474-e478.
    View in: PubMed
    Score: 0.105
  8. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy. Cancer. 2017 Sep 01; 123(17):3367-3376.
    View in: PubMed
    Score: 0.096
  9. Reply to J. Cabezas et al. J Clin Oncol. 2016 Jan 20; 34(3):290-1.
    View in: PubMed
    Score: 0.087
  10. HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract. 2015 Sep; 11(5):384-90.
    View in: PubMed
    Score: 0.085
  11. Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update. J Oncol Pract. 2015 Jul; 11(4):e487-9.
    View in: PubMed
    Score: 0.084
  12. Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update. J Clin Oncol. 2015 Jul 01; 33(19):2212-20.
    View in: PubMed
    Score: 0.083
  13. Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. BMC Cancer. 2013 Nov 09; 13:534.
    View in: PubMed
    Score: 0.075
  14. Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study. BMJ Support Palliat Care. 2012 Dec; 2(4):344-50.
    View in: PubMed
    Score: 0.069
  15. Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract. 2012 Jul; 8(4):e32-9.
    View in: PubMed
    Score: 0.068
  16. Accuracy of reporting current medications by cancer patients presenting to an emergency center. Support Care Cancer. 2010 Oct; 18(10):1347-54.
    View in: PubMed
    Score: 0.057
  17. Survival in cancer patients after out-of-hospital cardiac arrest. Support Care Cancer. 2010 Jan; 18(1):51-5.
    View in: PubMed
    Score: 0.055
  18. Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation. Cancer Res Commun. 2023 09 28; 3(9):1959-1965.
    View in: PubMed
    Score: 0.037
  19. False-reactive hepatitis B surface antigen test results in cancer patients. Eur J Clin Microbiol Infect Dis. 2023 03; 42(3):383-385.
    View in: PubMed
    Score: 0.036
  20. Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection. J Viral Hepat. 2021 05; 28(5):844-848.
    View in: PubMed
    Score: 0.031
  21. Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices. JAMA Oncol. 2019 Apr 01; 5(4):497-505.
    View in: PubMed
    Score: 0.027
  22. Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients. Future Oncol. 2016 May; 12(10):1219-31.
    View in: PubMed
    Score: 0.022
  23. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J. 2014 Jan-Feb; 20(1):8-14.
    View in: PubMed
    Score: 0.019
  24. Hepatitis B virus management to prevent reactivation after chemotherapy: a review. Support Care Cancer. 2012 Nov; 20(11):2999-3008.
    View in: PubMed
    Score: 0.017
  25. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012 Dec; 57(6):1177-85.
    View in: PubMed
    Score: 0.017
  26. Houston AANCART best practices: from vision to synergy to reality. Cancer. 2005 Dec 15; 104(12 Suppl):2909-15.
    View in: PubMed
    Score: 0.011
  27. Wide variation in content of inpatient do-not-resuscitate order forms used at National Cancer Institute-designated cancer centers in the United States. Support Care Cancer. 2009 Feb; 17(2):109-15.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.